NIH gives Venter's genomics institute $25M to decode infectious disease

NIH has signed on to give the J. Craig Venter Institute $25 million over 5 years to study infectious diseases including influenza and malaria, working to spotlight new treatments. The organization, founded by the eponymous gene sequencing pioneer and former NIH researcher, will tap more than 50 collaborators from about 40 institutes to break down the genomes of drug-resistant pathogens. The goal is to better understand some of the world's deadliest infections and fuel the effort to craft novel therapies. More from FierceBiotech IT

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.